A leaked draft from trade talks involving New Zealand shows multinational drug companies want patent rights strengthened, reducing peoples' access to cheaper drug substitutes.
A leaked draft from trade talks involving New Zealand shows multinational drug companies want patent rights strengthened, reducing peoples' access to cheaper drug substitutes.